AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7548380 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic treatment started before operation (Cefuroxime and Tinidazole)
Number of subjects: 234
Study 1971590 — intervention group
Group type: EXPERIMENTAL
Intervention: Xamoterol 0.2 mg kg‐1 i.v.
Number of subjects: 0
Study 1971590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 91482 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief acoustic stimuli at 70 dB SPL presented at various intervals (5 to 800 msec) prior to the eliciting stimulus
Number of subjects: 0
Study 91482 — intervention group
Group type: EXPERIMENTAL
Intervention: Similar stimuli with intensities varying from 30 to 70 dB SPL at a fixed lead time of 100 msec
Number of subjects: 0
Study 31711093 — intervention group
Group type: EXPERIMENTAL
Intervention: PC1 (negative loadings on uncultured Christensenellaceae and Ruminococcaceae)
Number of subjects: 319
Study 31711093 — intervention group
Group type: EXPERIMENTAL
Intervention: PC2 (positive loadings on Fusicatenibacter and Bifidobacterium; negative loadings on Bacteroides)
Number of subjects: 319
Study 31711093 — intervention group
Group type: EXPERIMENTAL
Intervention: PC3 (positive loadings on Faecalibacterium, Eubacterium, and Roseburia)
Number of subjects: 319
Study 31852699 — intervention group
Group type: EXPERIMENTAL
Intervention: POCT using the FilmArray respiratory panel
Number of subjects: 840
Study 31852699 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care
Number of subjects: 840
Study 28575331 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT) guided by oesophageal Doppler monitoring
Number of subjects: 100
Study 28575331 — intervention group
Group type: COMPARATOR
Intervention: Standard haemodynamic management (control group)
Number of subjects: 100
Study 24247999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex‐PRESS shunt with mitomycin-C
Number of subjects: 64
Study 24247999 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin-C
Number of subjects: 64
Study 23482600 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh-length graduated compression stockings (Trial 1)
Number of subjects: 5532
Study 23482600 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh-length graduated compression stockings (Trial 2)
Number of subjects: 5532
Study 23482600 — intervention group
Group type: COMPARATOR
Intervention: Below-knee graduated compression stockings (Trial 2)
Number of subjects: 5532
Study 21491012 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective tissue graft (CTG) + enamel matrix derivative (EMD)
Number of subjects: 56
Study 21491012 — intervention group
Group type: COMPARATOR
Intervention: Connective tissue graft (CTG) alone
Number of subjects: 56
Study 19622153 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodynamic evaluation followed by operative therapy
Number of subjects: 600
Study 19622153 — intervention group
Group type: COMPARATOR
Intervention: Urodynamic evaluation followed by individually tailored therapy
Number of subjects: 600
Study 19622153 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodynamic evaluation
Number of subjects: 600
Study 17106179 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestimide
Number of subjects: 33
Study 17106179 — intervention group
Group type: COMPARATOR
Intervention: Acarbose
Number of subjects: 33
Study 15242431 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of an ordinary paracetamol tablet
Number of subjects: 35
Study 15242431 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of an ordinary paracetamol tablet
Number of subjects: 35
Study 15242431 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of a bicarbonate paracetamol tablet
Number of subjects: 35
Study 15242431 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of a bicarbonate paracetamol tablet
Number of subjects: 35
Study 15242431 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g intravenously of prodrug propacetamol
Number of subjects: 35
Study 12072872 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency oscillatory ventilation (HFOV)
Number of subjects: 19
Study 12072872 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 19
Study 10321438 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based clinical decision support system (CDSS)
Number of subjects: 2239
Study 10321438 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2239
Study 7634866 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propafenone (2‐mg/kg bolus followed by 0.0078 mg/kg/min)
Number of subjects: 87
Study 7634866 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral propafenone (600 mg orally single dose)
Number of subjects: 87
Study 7634866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 2612238 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 40
Study 2612238 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 40
Study 674351 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (100 mg orally)
Number of subjects: 24
Study 674351 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofepramine (140 mg orally)
Number of subjects: 24
Study 674351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31776604 — intervention group
Group type: EXPERIMENTAL
Intervention: Scarpa's fascia preservation during abdominoplasty (n=21)
Number of subjects: 42
Study 31776604 — intervention group
Group type: COMPARATOR
Intervention: Fascia dissection during abdominoplasty (n=21)
Number of subjects: 42
Study 31688812 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower glucose target group
Number of subjects: 698
Study 31688812 — intervention group
Group type: COMPARATOR
Intervention: Higher glucose target group
Number of subjects: 698
Study 31688812 — intervention group
Group type: EXPERIMENTAL
Intervention: New or progressive multiple organ dysfunction syndrome
Number of subjects: 698
Study 31688812 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive multiple organ dysfunction syndrome
Number of subjects: 698
Study 31688812 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent multiple organ dysfunction syndrome
Number of subjects: 698
Study 27984466 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strength and endurance training program for 70 minutes per day, 3 days per week, for 8 weeks
Number of subjects: 15
Study 27984466 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise program)
Number of subjects: 15
Study 26992303 — intervention group
Group type: EXPERIMENTAL
Intervention: Polidocanol endovenous microfoam 1%
Number of subjects: 221
Study 23818410 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-trampoline group (n = 20)
Number of subjects: 40
Study 23818410 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 40
Study 21854285 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening, brief intervention, and referral to treatment model in medical EDs
Number of subjects: 0
Study 21854285 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 20146894 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg loading dose followed by 200 mg twice daily)
Number of subjects: 278
Study 20146894 — intervention group
Group type: COMPARATOR
Intervention: Non-selective NSAIDs (standard doses)
Number of subjects: 278
Study 17309762 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm dialysate condition (37 degrees C)
Number of subjects: 7
Study 17309762 — intervention group
Group type: COMPARATOR
Intervention: Cool dialysate condition (35 degrees C)
Number of subjects: 7
Study 14762409 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract extraction with acrylic intraocular lens implantation
Number of subjects: 49
Study 11431647 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal Crinone, 90 mg/day (n=51)
Number of subjects: 99
Study 11431647 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular Prontogest, 50 mg/day (n=48)
Number of subjects: 99
Study 11431647 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal Crinone, 90 mg/day
Number of subjects: 99
Study 11431647 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular Prontogest, 50 mg/day
Number of subjects: 99
Study 9506875 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg
Number of subjects: 513
Study 9506875 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 15 mg
Number of subjects: 513
Study 9506875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513
Study 9506875 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 30 mg
Number of subjects: 513
Study 29986745 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of aerobic exercise with targeted intensity
Number of subjects: 40
Study 29986745 — intervention group
Group type: COMPARATOR
Intervention: 8 weeks of leisure exercise
Number of subjects: 40
Study 28799823 — intervention group
Group type: COMPARATOR
Intervention: 2'-O-Methoxyethyl-modified antisense oligonucleotides (ASOs) administered at doses ranging from 50 to 450 mg via subcutaneous injection and up to 600 mg via intravenous infusion
Number of subjects: 10
Study 25748671 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% ethanol for 60 s before application of Single Bond 2
Number of subjects: 17
Study 25748671 — intervention group
Group type: EXPERIMENTAL
Intervention: Distilled water for 60 s before application of Single Bond 2
Number of subjects: 17
Study 25748671 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide lining before etching and bonding (control)
Number of subjects: 17
Study 24130362 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-s maximal sprint after moderate-intensity exercise
Number of subjects: 7
Study 24130362 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity exercise alone
Number of subjects: 7
Study 19823051 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent HPV vaccine (Cervarix)
Number of subjects: 47236
Study 19823051 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine (Gardasil)
Number of subjects: 47236
Study 19823051 — intervention group
Group type: COMPARATOR
Intervention: Bivalent and Quadrivalent HPV vaccines
Number of subjects: 47236
Study 17540225 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatization disorder patients
Number of subjects: 70
Study 17540225 — intervention group
Group type: COMPARATOR
Intervention: Mood and/or anxiety disorder patients (controls)
Number of subjects: 70
Study 15449353 — intervention group
Group type: EXPERIMENTAL
Intervention: Surprised faces
Number of subjects: 0
Study 15449353 — intervention group
Group type: COMPARATOR
Intervention: Neutral or disgust expressions
Number of subjects: 0
Study 11680648 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 65
Study 11680648 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied relaxation
Number of subjects: 65
Study 11680648 — intervention group
Group type: COMPARATOR
Intervention: Nitrous oxide sedation (control)
Number of subjects: 65
Study 9694550 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (36.64 mg daily for 3 years)
Number of subjects: 1000
Study 9694550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 7807754 — intervention group
Group type: EXPERIMENTAL
Intervention: B + S
Number of subjects: 94
Study 7807754 — intervention group
Group type: EXPERIMENTAL
Intervention: B + R
Number of subjects: 94
Study 7807754 — intervention group
Group type: EXPERIMENTAL
Intervention: B alone
Number of subjects: 94
Study 2772858 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen inhalation challenge
Number of subjects: 0
Study 2772858 — intervention group
Group type: COMPARATOR
Intervention: Phosphate buffered saline (control solution)
Number of subjects: 0
Study 17374 — intervention group
Group type: EXPERIMENTAL
Intervention: Metyrosine (administered for three weeks)
Number of subjects: 0
Study 31883218 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed/snacking dietary pattern
Number of subjects: 482
Study 31883218 — intervention group
Group type: EXPERIMENTAL
Intervention: African/Caribbean dietary pattern
Number of subjects: 482
Study 31883218 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy/prudent dietary pattern
Number of subjects: 482
Study 31883218 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower enjoyment of food and food responsiveness
Number of subjects: 482
Study 31387121 — intervention group
Group type: EXPERIMENTAL
Intervention: Menaquinone-7 (MK-7) 360 µg/d for 6 months
Number of subjects: 68
Study 31387121 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 68
Study 27778191 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 1800 mg/day
Number of subjects: 106
Study 27778191 — intervention group
Group type: COMPARATOR
Intervention: Control (statin therapy only)
Number of subjects: 106
Study 24833246 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoendoscopic single-site surgery (LESS)
Number of subjects: 35
Study 24833246 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic surgery
Number of subjects: 35
Study 23582440 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibered microcoils
Number of subjects: 43
Study 23582440 — intervention group
Group type: EXPERIMENTAL
Intervention: Detachable hydrogel-coated microcoils
Number of subjects: 43
Study 23582440 — intervention group
Group type: EXPERIMENTAL
Intervention: Pushable hydrogel-coated microcoils
Number of subjects: 43
Study 21491073 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week inpatient rehabilitation programme in a Mediterranean setting
Number of subjects: 107
Study 21491073 — intervention group
Group type: COMPARATOR
Intervention: 4-week inpatient rehabilitation programme in a Norwegian setting
Number of subjects: 107
Study 19423098 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatin-thrombin matrix (FloSeal Matrix)
Number of subjects: 50
Study 19423098 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study 17343981 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 350
Study 17343981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study 15533478 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic radical nephrectomy (LRN)
Number of subjects: 40
Study 15533478 — intervention group
Group type: COMPARATOR
Intervention: Retroperitoneoscopic radical nephrectomy (RRN)
Number of subjects: 40
Study 15533478 — intervention group
Group type: COMPARATOR
Intervention: Robotic assistance system (AESOP) with RRN
Number of subjects: 40
Study 11808544 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene therapy
Number of subjects: 2622
Study 10021954 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5%
Number of subjects: 61
Study 10021954 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.5%
Number of subjects: 61
Study 10021954 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 61
Study 7541310 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone (1 mg IV)
Number of subjects: 73
Study 7541310 — intervention group
Group type: COMPARATOR
Intervention: Meperidine (50 mg IV)
Number of subjects: 73
Study 3071325 — intervention group
Group type: EXPERIMENTAL
Intervention: 45-min exercise (50% of VO2 max) with real field exposure (9-kV/m, 16-A/m)
Number of subjects: 11
Study 3071325 — intervention group
Group type: COMPARATOR
Intervention: 45-min exercise (50% of VO2 max) with sham exposure
Number of subjects: 11
Study 3071325 — intervention group
Group type: EXPERIMENTAL
Intervention: No-exercise sessions with real field exposure (9-kV/m, 16-A/m)
Number of subjects: 11
Study 3071325 — intervention group
Group type: COMPARATOR
Intervention: No-exercise sessions with sham exposure
Number of subjects: 11
Study 31341133 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative predonated blood transfusion (group A)
Number of subjects: 53
Study 31341133 — intervention group
Group type: COMPARATOR
Intervention: Control group (group N)
Number of subjects: 53
Study 27613946 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous intensity supervised exercise (EX)
Number of subjects: 30
Study 27613946 — intervention group
Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 30
Study 27613946 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who smoked
Number of subjects: 30
Study 25819856 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental stress-induced myocardial ischemia (MSIMI) group
Number of subjects: 270
Study 25819856 — intervention group
Group type: COMPARATOR
Intervention: Normal left ventricular response to stress (NLVR) group
Number of subjects: 270
Study 25819856 — intervention group
Group type: COMPARATOR
Intervention: MSIMI group vs NLVR group
Number of subjects: 270
Study 25819856 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting platelet aggregation and serotonin transporter expression
Number of subjects: 270
Study 24015715 — intervention group
Group type: EXPERIMENTAL
Intervention: Biscuits (low glycemic index, high slowly available glucose)
Number of subjects: 25
Study 24015715 — intervention group
Group type: COMPARATOR
Intervention: Extruded cereals (medium GI, low SAG)
Number of subjects: 25
Study 21871144 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic fruit yoghurt 'mild' containing Lactobacillus acidophilus LA-5 plus Bifidobacterium lactis BB-12 (n=30)
Number of subjects: 88
Study 21871144 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasteurized probiotic fruit yoghurt (n=29)
Number of subjects: 88
Study 21871144 — intervention group
Group type: COMPARATOR
Intervention: Milk acidified with lactic acid (control, n=29)
Number of subjects: 88
Study 18770043 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistently high spirituality group
Number of subjects: 0
Study 18770043 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing spirituality group
Number of subjects: 0
Study 18770043 — intervention group
Group type: COMPARATOR
Intervention: Consistently low spirituality group
Number of subjects: 0
Study 18770043 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing spirituality group
Number of subjects: 0
Study 18770043 — intervention group
Group type: COMPARATOR
Intervention: Religiosity groups
Number of subjects: 0
Study 18770043 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirituality group membership
Number of subjects: 0
Study 18770043 — intervention group
Group type: COMPARATOR
Intervention: Religiosity group membership
Number of subjects: 0
Study 17362457 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrysof Natural IOL
Number of subjects: 93
Study 15657024 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice between 4 active alternatives or 4 sedentary alternatives (Group 1)
Number of subjects: 30
Study 15657024 — intervention group
Group type: EXPERIMENTAL
Intervention: Least valued sedentary activity (Group 2)
Number of subjects: 30
Study 15657024 — intervention group
Group type: EXPERIMENTAL
Intervention: Most valued sedentary activity (Group 3)
Number of subjects: 30
Study 11579250 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure to a partner
Number of subjects: 1078
Study 11579250 — intervention group
Group type: COMPARATOR
Intervention: Cohabiting, low wage employment, previous disclosure to a female relative, ever-use of modern contraceptive method
Number of subjects: 1078
Study 11579250 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer than six lifetime sexual partners, knowing someone with HIV/AIDS
Number of subjects: 1078
Study 11579250 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowing more than two individuals with HIV/AIDS, full economic dependency on partner, high levels of social support, prior attendance at a support group meeting
Number of subjects: 1078
Study 9649160 — intervention group
Group type: EXPERIMENTAL
Intervention: MVP (mitomycin‐C 6 mg m(‐2) on day 1, vindesine 3 mg m(‐2) on days 1 and 15, and cisplatin 80 mg m(‐2) on day 1 every 28 days)
Number of subjects: 140
Study 9649160 — intervention group
Group type: EXPERIMENTAL
Intervention: PIN (cisplatin 80 mg m(‐2) day 1, ifosfamide 3 g m(‐2) day 1 and vinorelbine 25 mg m(‐2) day 1 and 8 every 21 days)
Number of subjects: 140
Study 9649160 — intervention group
Group type: EXPERIMENTAL
Intervention: CaN (carboplatin 350 mg m(‐2) day 1 and vinorelbine 25 mg m(‐2) days 1 and 8 every 28 days)
Number of subjects: 140
Study 7913675 — intervention group
Group type: COMPARATOR
Intervention: Active control trials with a specified region of therapeutic equivalence for two responses related to efficacy
Number of subjects: 0
Study 7913675 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivariate group sequential design
Number of subjects: 0
Study 2688238 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine insulin (PI)
Number of subjects: 8
Study 2688238 — intervention group
Group type: EXPERIMENTAL
Intervention: Human insulin (HI)
Number of subjects: 8
Study 1089678 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 μg GnRH/m2 iv in children
Number of subjects: 29
Study 1089678 — intervention group
Group type: EXPERIMENTAL
Intervention: 1, 10, 25, and 100 μg GnRH/m2 iv in adults
Number of subjects: 29
Study 1089678 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH iv at 10 μg/m2 in children
Number of subjects: 29
Study 1089678 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH iv in adults
Number of subjects: 29
Study 1089678 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH iv in children and adults
Number of subjects: 29
Study 31314206 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweetened beverages consumption (≥500 ml daily)
Number of subjects: 931
Study 27542378 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia self-management intervention for lung surgery preparation
Number of subjects: 0
Study 27542378 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 26992066 — intervention group
Group type: EXPERIMENTAL
Intervention: A Controlled Comparison of Eritoran and placebo in patients with Severe Sepsis
Number of subjects: 2129
Study 26992066 — intervention group
Group type: EXPERIMENTAL
Intervention: PROWESS‐SHOCK
Number of subjects: 2129
Study 24835760 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral-domain optical coherence tomography (SD OCT)
Number of subjects: 384
Study 24835760 — intervention group
Group type: COMPARATOR
Intervention: Time-domain optical coherence tomography (TD OCT)
Number of subjects: 384